Project Grant HT94252411008
Award Date
11/15/24
Completion Date
11/14/27
Dollars Obligated
$689K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Little Rock, AR 72205, USA
Similar Awards
This $298,329 federal Project Grant awarded by the Defense Health Agency on March 1, 2024 under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Arkansas for Medical Sciences (UAMS) on the role of subchondral bone osteocytes in post-traumatic osteoarthritis. UAMS, a major academic medical center, will leverage its expertise in biomedical research to investigate this specific aspect of osteoarthritis development over the 2-year award...
The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This $1,555,176 federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) will support the University of Michigan's research on therapeutic modulation of the serine/threonine phosphatase PP2A for the treatment of uterine serous cancer (USC) and uterine carcinosarcoma (UCS). The award, which runs from Aug 2024 to Aug 2027, will enable the University to conduct advanced biomedical research aimed at transforming...
This federal Project Grant award from the U.S. Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $516,000.00 to Mainehealth, a non-profit healthcare system in Portland, Maine, to develop a novel ovarian cancer treatment targeting a unique extracellular matrix component using an antibody conjugate. This 2-year research project, which commenced on May 15, 2024, aims to advance innovative cancer treatment approaches with...
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The University of Cambridge will receive $439,922 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from September 2022 through September 2025 to dissect ovarian cancer tumor-immune microenvironments through 3D in situ molecular profiling. The Military Medical Research and Development program aims to transform military and public health through innovative medical research...
This Project Grant award, valued at $541,837.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at the University of Oklahoma Health Sciences Center, with the aim of developing a drug-targeting ORP4 as a precision ovarian cancer treatment. The award period runs from May 1, 2025 to April 30, 2029, leveraging the university's expertise in medical research and product development...
Oregon Health & Science University was awarded a $506,554 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. Through basic, applied, and advanced biomedical research supported by this program, the Army aims to transform military and public health care by...
This Project Grant award in the amount of $464,234.00 was issued by the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The funding supports advanced biomedical research focused on investigating the role of the TP53 P72R single nucleotide polymorphism (SNP) in high-grade serous carcinoma, a type of ovarian cancer. The research is being conducted by the University of California, Davis, a prominent public land-grant...
This $785,833 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. Awarded to the University of Wisconsin System, the research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis,...